These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19877499)
1. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. Müller N; Myint AM; Schwarz MJ Dialogues Clin Neurosci; 2009; 11(3):319-32. PubMed ID: 19877499 [TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibition in schizophrenia and major depression. Müller N; Schwarz MJ Curr Pharm Des; 2008; 14(14):1452-65. PubMed ID: 18537668 [TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Müller N Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157 [TBL] [Abstract][Full Text] [Related]
12. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Müller N; Schwarz MJ Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():97-106. PubMed ID: 18516521 [TBL] [Abstract][Full Text] [Related]
13. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Müller N; Schwarz MJ Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312 [TBL] [Abstract][Full Text] [Related]
17. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Stone TW Trends Pharmacol Sci; 2000 Apr; 21(4):149-54. PubMed ID: 10740291 [TBL] [Abstract][Full Text] [Related]